Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
AstraZeneca
Hoffmann-La Roche
Baylor College of Medicine
University of Nebraska
VM Oncology, LLC
Cancer Research UK
Bayer
LigaChem Biosciences, Inc.
University of Colorado, Denver
Merck Sharp & Dohme LLC
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
OncoC4, Inc.
Taproot Health
Convalife (Shanghai) Co., Ltd.
Universitair Ziekenhuis Brussel
Hoffmann-La Roche
Stanford University
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
AIDS Malignancy Consortium
National Cancer Institute (NCI)
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Vanderbilt University Medical Center
OHSU Knight Cancer Institute
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Duke University